|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|
| Net revenue | ||
| Costs and expenses: | ||
| Cost of net revenue, exclusive of depreciation and amortization | ||
| Operations and support | ||
| Research and development | ||
| Marketing | ||
| General and administrative | ||
| Depreciation and amortization | ||
| Total costs and expenses | ||
| (Loss) income from operations | ||
| Interest income | ||
| Other expense, net | ||
| Change in fair value of redeemable convertible preferred stock warrant liability | ||
| Change in fair value of convertible notes | ||
| Loss on extinguishment of convertible notes | ||
| Change in fair value of contingent consideration | ||
| Other, net | ||
| Other expenses, net | ||
| (Loss) income before (benefit) provision for income taxes | ||
| (Benefit) provision for income taxes | ||
| Net (loss) income | ||
| Undistributed earnings attributable to participating securities | ||
| Net (loss) income attributable to common stockholders | ||
| Net (loss) income per share attributable to common stockholders, basic | ||
| Net (loss) income per share attributable to common stockholders, diluted | ||
| Weighted-average number of shares outstanding used to compute net (loss) income per share attributable to common stockholders, basic | ||
| Weighted-average number of shares outstanding used to compute net (loss) income per share attributable to common stockholders, diluted |
Loading...
